<DOC>
	<DOCNO>NCT02835404</DOCNO>
	<brief_summary>The objective study evaluate efficacy complication treatment pelvic external combine 252-Cf neutron intracavitary radiotherapy without platinum local advance cervical cancer patient short long term .</brief_summary>
	<brief_title>Pelvic External Combined With 252-Cf Neutron Intracavitary Radiotherapy With Without Platinum Treating Advanced Cervical Cancer</brief_title>
	<detailed_description />
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<mesh_term>Nedaplatin</mesh_term>
	<criteria>1 . To age 18 ( include 18 ) 65 ( include 65 ) , female patient ; 2 . Expected survival ≥6 month 3 . Pathologically proven diagnosis squamous carcinoma adenocarcinoma cervix , accord FIGO ( International Federation Gynecology Obstetrics ) staging , appropriate stage protocol entry , include IIA2 , IIB , IIIA , IIIB ; 4 . No patient distant metastasis ; 5 . Measurable target lesion ( satisfy criterion RECIST 1.1 ) ; 6 . ECOG PS status 02 ; 7 . No prior treatment ; 8 . No 9 . No surgery 10 . Major organ function meet follow criterion : 1 . Bilirubin &lt; 1.5 time upper limit normal ( ULN ) 2 . ALT , AST APL≤2.5 × ULN 3 . NEUT≥2.0 × 10^9 / L 4 . PLT ≥ 100 × 10^9 / L 5 . HB≥60g/L 6 . Serum Cr urea nitrogen ≤ 1.5 × ULN 11 . Favorable cardiac function , patient myocardial infarction within half year , hypertension coronary disease wellcontrolled . 1 . Serious heart disease , pulmonary disease , hepatic disease , , renal disease metabolic disease , electrolyte disturbance ; 2 . Allergic platinum ; 3 . Rejecte join study condition .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>